Related Experiment Video
Updated: Oct 18, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Association of Derived Neutrophil-To-Lymphocyte Ratio With Prognosis of Coronary Heart Disease After PCI
Gang-Qiong Liu1, Wen-Jing Zhang1, Jia-Hong Shangguan1,2
1Department of Cardiology, Key Laboratory of Cardiac Injury and Repair of Henan Province, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Insights
The derived neutrophil-to-lymphocyte ratio (dNLR) predicts mortality in coronary heart disease (CHD) patients post-PCI. Higher dNLR levels correlate with increased risks of all-cause and cardiac mortality, indicating its prognostic value.
Area of Science:
- Cardiology
- Biomarkers
- Clinical Research
Background:
- Coronary heart disease (CHD) remains a leading cause of mortality worldwide.
- Percutaneous coronary intervention (PCI) is a common revascularization strategy for CHD.
- Identifying reliable prognostic markers post-PCI is crucial for patient management.
Purpose of the Study:
- To investigate the prognostic significance of the derived neutrophil-to-lymphocyte ratio (dNLR) in patients with CHD following PCI.
- To evaluate the association between dNLR tertiles and adverse outcomes, including mortality and major adverse cardiovascular events (MACEs).
Main Methods:
- Retrospective analysis of 3,561 CHD patients undergoing PCI (CORFCHD-ZZ study, 2013-2017).
- Patients stratified into three dNLR tertiles: <1.36, 1.36-1.96, and ≥1.96.
- Primary endpoint: mortality (all-cause and cardiac death); Secondary endpoints: MACEs and MACCEs; Mean follow-up: 37.59 months.
Main Results:
- Higher dNLR tertiles were associated with significantly increased all-cause mortality (ACM) and cardiac mortality (CM) in the overall cohort.
- Multivariate analysis confirmed dNLR as an independent predictor: higher dNLR increased ACM risk by 1.763 times and CM risk by 1.961 times.
- Significant differences in ACM incidence observed across dNLR tertiles in both acute coronary syndrome (ACS) and chronic coronary syndrome (CCS) patients; CM differences were significant in CCS patients.
Conclusions:
- The derived neutrophil-to-lymphocyte ratio (dNLR) serves as an independent and novel predictor of mortality in CHD patients after PCI.
- dNLR stratification can aid in risk stratification and long-term management of post-PCI CHD patients.
- Further research may explore therapeutic strategies targeting inflammation indicated by dNLR.
Abstract:
Aims: The present study aimed to investigate the prognostic role of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with coronary heart disease (CHD) after PCI. Methods: A total of 3,561 post-PCI patients with CHD were retrospectively enrolled in the CORFCHD-ZZ study from January 2013 to December 2017. The patients (3,462) were divided into three groups according to dNLR tertiles: the first tertile (dNLR < 1.36; n = 1,139), second tertile (1.36 ≥ dNLR < 1.96; n = 1,166), and third tertile(dNLR ≥ 1.96; n = 1,157). The mean follow-up time was 37.59 ± 22.24 months. The primary endpoint was defined as mortality (including all-cause death and cardiac death), and the secondary endpoint was major adverse cardiovascular events (MACEs) and major adverse cardiovascular and cerebrovascular events (MACCEs). Results: There were 2,644 patients with acute coronary syndrome (ACS) and 838 patients with chronic coronary syndrome (CCS) in the present study. In the total population, the all-cause mortality (ACM) and cardiac mortality (CM) incidence was significantly higher in the third tertile than in the first tertile [hazard risk (HR) = 1.8 (95% CI: 1.2-2.8), p = 0.006 and HR = 2.1 (95% CI: 1.23-3.8), p = 0.009, respectively]. Multivariate Cox regression analyses suggested that compared with the patients in the first tertile than those in the third tertile, the risk of ACM was increased 1.763 times (HR = 1.763, 95% CI: 1.133-2.743, p = 0.012), and the risk of CM was increased 1.763 times (HR = 1.961, 95% CI: 1.083-3.550, p = 0.026) in the higher dNLR group during the long-term follow-up. In both ACS patients and CCS patients, there were significant differences among the three groups in the incidence of ACM in univariate analysis. We also found that the incidence of CM was significantly different among the three groups in CCS patients in both univariate analysis (HR = 3.541, 95% CI: 1.154-10.863, p = 0.027) and multivariate analysis (HR = 3.136, 95% CI: 1.015-9.690, p = 0.047). Conclusion: The present study suggested that dNLR is an independent and novel predictor of mortality in CHD patients who underwent PCI.
More Related Videos
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...